Does left ventricular hypertrophy influence cardiac prognosis in patients undergoing dobutamine cardiac stress testing?
LVH is predictive of future MI and cardiac death in patients with or without inducible ischemia during dobutamine cardiac stress testing. As a result, LVH should be reported in those referred for dobutamine cardiac stress tests, particularly in those without inducible ischemia, in whom one would otherwise assume a favorable cardiac prognosis.
Despite 10% of patients choosing to delay attendance beyond 48 h, no adverse public health outcomes were demonstrated.